September 26, 2022
In the first known study of its type, an international team of researchers evaluated whether high research and development costs explain high drug prices in the United States. They found no such association for 60 new drugs approved from 2009 to 2018.
June 28, 2023
UC San Diego researchers find a combination of drugs outperformed other treatments in human and mouse models of pancreatic cancer; now urge clinical trial
October 31, 2022
Computational chemistry affects everyday life more than most people might realize. It is used to develop drugs to treat diseases, generate data for environmental clean-up purposes, design solar energy technology, improve batteries, create enzymes to break down plastics and more.
January 31, 2023
UC San Diego scientists developed an artificial intelligence tool that could accelerate the development of new high affinity antibody drugs.
July 18, 2016
Biochemists at the University of California San Diego have developed artificial cell membranes that grow and remodel themselves in a manner similar to that of living mammalian cells.
December 5, 2013
…San Diego Biophysicists Examine Development of Antibiotic Resistance A team of UC San Diego biophysicists used quantitative models of bacterial growth to discover the bizarre way by which antibiotic resistance allows bacteria to multiply in the presence of antibiotics, a growing health problem in hospitals and nursing homes across the…
April 11, 2024
Researchers from UC San Diego have discovered the biochemical workings of an old-fashioned diabetes drug, and it’s helping them develop new, safer alternatives.
September 13, 2018
…identified three new molecular drug targets in Naegleria fowleri and a number of drugs that are able to inhibit the amoeba’s growth in a laboratory dish. Several of these drugs are already approved by the U.S. Food and Drug Administration for other uses, such as antifungal agents, the breast cancer…
November 2, 2015
…California, San Diego have developed a model that could be used to predict a drug’s side effects on different patients. The proof of concept study is aimed at determining how different individuals will respond to a drug treatment and could help assess whether a drug is suitable for a particular…
November 20, 2014
…Briefs Congress on Brain Development, Substance Use in Young Organized by APA, Congressional Briefing Draws Large Crowd Sandra A. Brown, vice chancellor for research at UC San Diego, was a featured speaker at an October Congressional Briefing in Washington, D.C., where she shared important findings on adolescent neurodevelopment with other…
